Genetic testing may help select women with ER+ breast cancer for extended hormone the

[News]

Genetic analyses of results from 1125 postmenopausal women being treated for oestrogen responsive breast cancer have shown that some of them are more likely than others to have a late recurrence of their cancer and might benefit from ten years of hormone therapy rather than five.

More... (http://www.news-medical.net/news/20140319/Genetic-testing-may-help-select-women-with-ER2b-breast-cancer-for-extended-hormone-therapy.aspx)